Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and older
In RFA for tumors with diameters of ≤3 cm and ≤3 HCC nodules, age over ≥80 years was not a significant factor associated with OS or liver disease-related death. The results support that RFA would be a promising treatment option for patients with HCC patients aged ≥80 years.
Authors
- Yutaka Yasui (ORCID: https://orcid.org/0000-0002-7717-8638)
- Kenta Takaura (ORCID: https://orcid.org/0000-0003-2644-8084)
- Haruka Miyamoto
- Taisei Keitoku (ORCID: https://orcid.org/0000-0002-3373-2940)
- Kaoru Tsuchiya (ORCID: https://orcid.org/0000-0003-0436-5915)
- Nobuharu Tamaki
- Mayu Higuchi
- Y. Tokunaga (ORCID: https://orcid.org/0000-0002-6364-786X)
- Shohei Kimura (ORCID: https://orcid.org/0009-0004-2162-7176)
- Masayuki Taguchi
- Shohei Tanaka (ORCID: https://orcid.org/0000-0002-4257-5342)
- Naoki Uchihara
- Chiaki Maeyashiki (ORCID: https://orcid.org/0000-0003-3026-7438)
- Masayuki Kurosaki (ORCID: https://orcid.org/0000-0001-7016-8931)
- Yuka Takahashi
- Hiroyuki Nakanishi
- Yuuki Tanaka (ORCID: https://orcid.org/0000-0002-0871-1726)
- Risa Okada
- Namiki Izumi
- Junko Yagita
Institutions
- Musashino Red Cross Hospital (JP)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1371/journal.pone.0334712
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00